FreeGuest Editorial Fly the pride flag—and free the LGBTQ+ community from the oppression of smoking June 25, 2021Vol.47 No.25By Phoenix A. Matthews
FreeGuest Editorial Let’s stop passing the buck on sexual harassment in academic medicine June 25, 2021Vol.47 No.25By Shikha Jain, Arghavan Salles and Vineet Arora
Free Pazdur expresses “profound concerns” about single-arm studies of PD-1/PD-L1 drugs; ODAC nixes retifanlimab for anal cancer June 25, 2021Vol.47 No.25By Paul Goldberg
Free NCI BSA approves four new concepts, concurs with 31 reissue PARs June 25, 2021Vol.47 No.25By Alexandria Carolan
FreeIn the Archives Betty Ford and the press conference that changed oncology June 25, 2021Vol.47 No.25By Katie Goldberg
NCI Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15% June 18, 2021Vol.47 No.24By Alexandria Carolan
News Analysis ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors June 18, 2021Vol.47 No.24By Matthew Bin Han Ong
Trials & Tribulations Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA June 18, 2021Vol.47 No.24By Howard S. Hochster and Michael P. Kane
FreeIn the Archives On the shoulders of giants: Research milestones and the Rabson-Kirschstein photo archive June 18, 2021Vol.47 No.24
EditorialFree The Cancer Letter receives 8 journalism, design awards June 18, 2021Vol.47 No.24By Paul Goldberg
